Oral Budesonide Suspension (OBS) in Adolescent and Adult

Project: Research project

Project Details

Description

Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) with Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
StatusActive
Effective start/end date3/24/163/24/21

Funding

  • SHIRE HUMAN GENETIC THERAPIES, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.